BDBM251693 US10100018, Example 29::US9464060, 29

SMILES: COc1ccccc1Oc1ccc(cc1)C(=O)N(CC(F)F)Cc1ccc(cc1)C(O)=O

InChI Key: InChIKey=YOVTYVMJDJNYKX-UHFFFAOYSA-N

Data: 4 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 251693   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Lysophosphatidic acid receptor 5 (LPA5) (Homo sapiens (Human))	BDBM251693 (US10100018, Example 29 | US9464060, 29) Show SMILES COc1ccccc1Oc1ccc(cc1)C(=O)N(CC(F)F)Cc1ccc(cc1)C(O)=O Show InChI InChI=1S/C24H21F2NO5/c1-31-20-4-2-3-5-21(20)32-19-12-10-17(11-13-19)23(28)27(15-22(25)26)14-16-6-8-18(9-7-16)24(29)30/h2-13,22H,14-15H2,1H3,(H,29,30)	UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	43	n/a	n/a	n/a	n/a	n/a	37
Takeda Pharmaceutical Company Limited US Patent					Assay Description Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ...				US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0
					More data for this Ligand-Target Pair
Lysophosphatidic acid receptor 1 (Homo sapiens (Human))	BDBM251693 (US10100018, Example 29 | US9464060, 29) Show SMILES COc1ccccc1Oc1ccc(cc1)C(=O)N(CC(F)F)Cc1ccc(cc1)C(O)=O Show InChI InChI=1S/C24H21F2NO5/c1-31-20-4-2-3-5-21(20)32-19-12-10-17(11-13-19)23(28)27(15-22(25)26)14-16-6-8-18(9-7-16)24(29)30/h2-13,22H,14-15H2,1H3,(H,29,30)	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	43	n/a	n/a	n/a	n/a	n/a	25
Takeda Pharmaceutical Company Limited US Patent					Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i...				US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N
					More data for this Ligand-Target Pair
Lysophosphatidic acid receptor 1 (Homo sapiens (Human))	BDBM251693 (US10100018, Example 29 | US9464060, 29) Show SMILES COc1ccccc1Oc1ccc(cc1)C(=O)N(CC(F)F)Cc1ccc(cc1)C(O)=O Show InChI InChI=1S/C24H21F2NO5/c1-31-20-4-2-3-5-21(20)32-19-12-10-17(11-13-19)23(28)27(15-22(25)26)14-16-6-8-18(9-7-16)24(29)30/h2-13,22H,14-15H2,1H3,(H,29,30)	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	n/a	25
Takeda Pharmaceutical Company Limited US Patent					Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i...				US Patent US10100018 (2018) BindingDB Entry DOI: 10.7270/Q2PR7Z0N
					More data for this Ligand-Target Pair
Lysophosphatidic acid receptor 1 (Homo sapiens (Human))	BDBM251693 (US10100018, Example 29 | US9464060, 29) Show SMILES COc1ccccc1Oc1ccc(cc1)C(=O)N(CC(F)F)Cc1ccc(cc1)C(O)=O Show InChI InChI=1S/C24H21F2NO5/c1-31-20-4-2-3-5-21(20)32-19-12-10-17(11-13-19)23(28)27(15-22(25)26)14-16-6-8-18(9-7-16)24(29)30/h2-13,22H,14-15H2,1H3,(H,29,30)	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	34	n/a	n/a	n/a	n/a	n/a	37
Takeda Pharmaceutical Company Limited US Patent					Assay Description Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ...				US Patent US9464060 (2016) BindingDB Entry DOI: 10.7270/Q23R0RT0
					More data for this Ligand-Target Pair